DOES O-METHYL-DOPA PLAY A ROLE IN LEVODOPA-INDUCED DYSKINESIAS?
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 56 (1), 79-82
- https://doi.org/10.1111/j.1600-0404.1977.tb01411.x
Abstract
Clinically scored levodopa-induced dyskinesias were correlated with plasma dopa and O-methyl-dopa levels determined every hour during one day in 30 Parkinsonian-treated patients. In patients treated with a combination of L-dopa and a peripheral decarboxylase inhibitor (PDI), those with dyskinesias have very high plasma O-methyl-dopa levels compared with those who have no dyskinesias. In contrast, no significantly different plasma dopa levels are found in these two subgroups of patients, leaving open the question of the possible involvement of such elevated plasma O-methyl-dopa levels in favouring dyskinesias.Keywords
This publication has 9 references indexed in Scilit:
- CHOREA AND TORSION IN PARKINSONISMThe Lancet, 1976
- DIPHASIC DYSKINESIA DURING LEVODOPA THERAPYThe Lancet, 1975
- 3-O-methyl metabolites of catecholamines: Automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopaBiochemical Medicine, 1974
- Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylaseJournal of the Neurological Sciences, 1972
- Effects of peripheral aromatic l-amino acids decarboxylase inhibitor on L-[2-14C]-3,4-dihydroxy-phenylalanine metabolism in manBiochemical Pharmacology, 1972
- 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- Postsynaptic Supersensitivity after 6‐Hydroxy‐dopamine Induced Degeneration of the Nigro‐striatal Dopamine SystemActa Physiologica Scandinavica, 1971
- Parkinsonisme et métabolisme plasmatique de la dihydroxyphénylalanine administrée avec un inhibiteur de la décarboxylaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Plasma DOPA response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitorClinical Pharmacology & Therapeutics, 1971